Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

A mutation in the VDR gene affects hair cycling without needing ligand binding.

The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.

Silencing NtNCED3-2 gene in tobacco reduces drought tolerance and impairs growth.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Certain gene variations and low adiponectin levels may increase the risk of hair loss in Egyptians.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

A new enzyme in rats may help regulate hair growth.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Thyroid receptor β can help develop new drugs to treat hair loss.

PDRN from salmon may slow skin aging by improving skin quality and reducing inflammation.

A new method to make finasteride for hair loss treatment was developed.

Activating ALDH2 can boost hair growth.

High energy boosts root hair growth in plants, while low energy stops it.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.